United States · FDA National Drug Code directory
Medroxyprogesterone Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70700-315_1a9d4cef-846b-2f23-65e1-7d4d4231f1cc
- Product NDC
- 70700-315
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Medroxyprogesterone Acetate
- Labeler
- Xiromed LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240312
- Source listing expiry
- 20271231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (70700-315-25) / 1 mL in 1 VIAL (70700-315-22) · 70700-315-25
- 1 VIAL in 1 CARTON (70700-315-27) / 1 mL in 1 VIAL (70700-315-22) · 70700-315-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →